
### [MONDO:0017773](http://purl.obolibrary.org/obo/MONDO_0017773)
**Label:** hypoalphalipoproteinemia

**Subclasses:** [MONDO:0018999](http://purl.obolibrary.org/obo/MONDO_0018999) (LCAT deficiency), [MONDO:0011393](http://purl.obolibrary.org/obo/MONDO_0011393) (apolipoprotein a-i deficiency), [MONDO:0007620](http://purl.obolibrary.org/obo/MONDO_0007620) (fish-eye disease), [MONDO:0008783](http://purl.obolibrary.org/obo/MONDO_0008783) (Tangier disease), [MONDO:0009515](http://purl.obolibrary.org/obo/MONDO_0009515) (Norum disease), 

**Corr. equiv. classes:** [Orphanet:650](http://www.orpha.net/ORDO/Orphanet_650), [OMIM:604091](http://purl.obolibrary.org/obo/OMIM_604091), [OMIM:205400](http://purl.obolibrary.org/obo/OMIM_205400), [OMIM:136120](http://purl.obolibrary.org/obo/OMIM_136120), [Orphanet:79292](http://www.orpha.net/ORDO/Orphanet_79292), [Orphanet:79293](http://www.orpha.net/ORDO/Orphanet_79293), [OMIM:245900](http://purl.obolibrary.org/obo/OMIM_245900), [Orphanet:31150](http://www.orpha.net/ORDO/Orphanet_31150), [Orphanet:425](http://www.orpha.net/ORDO/Orphanet_425), 

**Class expressions from DL-Learner:**

- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity) 73.42%
- [HP:0000481](http://purl.obolibrary.org/obo/HP_0000481) (Abnormality of the cornea) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) 73.42%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 70.04%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 67.31%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 67.31%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) 67.31%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 66.67%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0001744](http://purl.obolibrary.org/obo/HP_0001744) (Splenomegaly) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 66.67%
- [HP:0001744](http://purl.obolibrary.org/obo/HP_0001744) (Splenomegaly) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity) 66.67%


